GBS begins with tingling or numbness in the feet and hands, followed by muscle weakness and difficulty moving joints.
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...